Changing FDA Approval Standards: Ethical Implications for Patient Consent

Ítems similars

• Evaluation of technologies approved for supplemental payments in the United States
  per: Judson, Timothy J, et al.
  Publicat: (2019)
• Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements
  per: Zheng, Sarah Y., et al.
  Publicat: (2017)
• Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program
  per: Jones, L. Camille, et al.
  Publicat: (2018)
• Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices
  per: Dhruva, Sanket S., et al.
  Publicat: (2017)
• FDA: Evidentiary Standards for Drug Development and Approval
  per: Katz, Russell
  Publicat: (2004)